跳至主要内容
临床试验/ITMCTR2100004467
ITMCTR2100004467招募中1 期

Application and evaluation of Syndrome differentiation Xerox in chronic disease management of patients with advanced lung cancer

Dongfang Hospital of Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
45 至 80(—)
性别
All

入选标准

  • 1. Patients aged 45-80 years old;
  • 2. Patients meeting the diagnostic criteria of advanced lung cancer;
  • 3. Patients who met the diagnostic criteria of anxiety state;
  • 4. Patients meeting the diagnostic criteria of sleep disorders;
  • 5. Subjects with informed consent signed the informed consent.

排除标准

  • 1. Patients with serious primary diseases or complications such as heart, liver, lung, kidney, etc;
  • 2. Patients whose expected survival time is less than 6 months;
  • 3. Patients who cannot cooperate with music therapy;
  • 4. Patients who participated in any clinical trial within 30 days before screening;
  • 5. Patients with any concomitant diseases that may interfere with the trial procedure or evaluation, or other conditions considered unsuitable by the researchers.

研究者

发起方
Dongfang Hospital of Beijing University of Chinese Medicine

相似试验

Application and evaluation of Syndrome... | 临床试验